You are on page 1of 42

GLOBAL OPPRTUNITIES FOR AYUSH

AND ROLE OF PHARMEXCIL


NAME : RENUKA PARESH J
SEM-I
MBA(PHARMA)
NIPER
CONCLUSION
ROLE OF PHARMEXCIL
AYUSH
CURRENT DRUG DISCOVER SCENARIO
FLOW OF PRESENTATION
Current scenario of drug discovery
For the develping country like india it is not possible to
invest billions of dollars on the R & D because there
are mare chances of success

Some times the drugs are failed in phase ii and phase


iii and the whole money invested for that is wasted

India is not able to discover a single block buster


molecule because of lack in R & D
India is the land of biodiversity

India has the great traditional knowledge of ayurveda


and siddha

India has literature like charak samhita , shushrut


samhita , and many ancient literature claiming to cure
incurabale killer disease
But all the scripting is in sanskrit and no scientific
evidence is there to claim in the international martket

Qc testing lab for the traditional medicines are very


less in india

Work for novel natural molecule is at the emerging


stage
Deptt of Ayush
Ayurveda, Siddha, Unani and Homeopathy

Department of Indian Systems of Medicine and


Homoeopathy (ISM&H) was created in March,1995
and re-named as (Department of Ayurveda, Yoga &
Naturopathy, Unani, Siddha and Homoeopathy

(AYUSH) in November, 2003 with a view to


providing focused attention to development of
Education & Research in Ayurveda, Yoga &
Naturopathy, Unani, Siddha and Homoeopathy
systems.
The Department continued to lay emphasis on
upgradation of AYUSH educational standards, quality
control and standardization of drugs,

 improving the availability of medicinal plant material,


research and development and awareness generation
about the efficacy of the systems domestically and
internationally.
BACKGROUND OF AYUSH IN INDIA
Ayurveda - A Complete Science Of Life
Ayurveda (Sanskrit: आयर्वेु द; Āyurveda, the "science of life")
or ayurvedic medicine is a system of traditional medicine
native to the Indian subcontinent and practiced in other
parts of the world as a form of alternative medicine

In Sanskrit, the word ayurveda consists of the words


āyus, meaning "longevity", and veda, meaning "related to
knowledge" or "science".
 Evolving throughout its history, ayurveda remains an
influential system of medicine in South Asia.

 The earliest literature on Indian medical practice


appeared during the Vedic period in India.

The Suśruta Saṃhitā and the Charaka Saṃhitā were


influential works on traditional medicine during this era
principals
STATUS OUTSIDE INDIA
The US National Center for Complementary and Alternative Medicine

The European Federation for Complementary and Alternative


Medicine

The European Ayurveda Association

In 2009, the United States of America National Center for


Complementary and Alternative Medicine

(NCCAM) of the National Institutes of Health expended $1.2 million of


its $123 million annual budget on ayurvedic medicine-related
research.
CASE STUDY

 Patents
 In December 1993, the University ofMississippiMedical
Center had a patent issued to them by United States Patent
and Trademark Office on the use of turmeric for healing.

 The patent was contested by India's industrial research


organization, Council for Scientific and Industrial Research
(CSIR),

 on the grounds that traditional ayurvedic practitioners


were already aware of the healing properties of the
substance for centuries, and that this prior art made the
patent a case of bio-piracy
Scientific evidence
.
As a traditional medicine, many ayurveda products
have not been tested in rigorous scientific studies and
clinical trials

.In India, research in ayurveda is largely undertaken by


the statutory body of the Central Government, the
Central Council for Research in Ayurveda and Siddha
(CCRAS), through a national network of research
institutes.
Ayurvedic products

Arishtha
Vati
Bhashma
Churna
Avleha
HERBAL PRODUCTS
HOMEOPATHY
UNANI

UNANI MEDICINE:- According to Unani medicine,


management of any disease depends on the cause,
aggravating factors, pathogenesis, pathology, and clinical
manifestations.

Any cause and or factor is countered by the power of


body responsible to maintain health) the failing of which
may lead to quantitatively or qualitatively dearangement
of the normal equilibrium of akhlat( humors ) of body
which constitute the tissues and organs.
SIDHHA
Agasthyar a great dravidian guru who is belived to
b the father of the siddha system

One of the most ancint medical wisdom of the


mankind

Siddha vaidyam is the vast ocean of the scientific


knowledge and every drop of it is divine.
Tamil is the language of the siddha vaidyam and
proclaims that siddha wisdom has been origanated
from the parmshivam himself

Siddha vaidyam can be defined as the comprehansive


and scientific system of medicine

Which diagnsose all types of human ailements by


gauging the pulse of das nadis (principal ten nerves)
And cures the disease by aministering the elixir like
medicine of plants and natural resources.

Neetumarunmukual – herbs prepared from the metals and


the 64 types of the poisionous substances giving extra
curing edge to the siddha system

Siddha system offers treatment for 4400 type of ailments


including common cough and cold to killer disease like
cancer and diabetes
Siddha system classify disease in to three sections

Saadhyam – these are the disease which are cured


withijn the span of one mandalam ( 41 days)

Klishta saadhyam – for that one to three years are


required

Assadhyam – siddha system will improve the condition of


the patients of assadhyam category
Popular medical sciences including modern medicines
may wilt and turn in effective before some of the so
called incurable disease like asthma , psoriasis, hyper
tension, rheumatoid artharitis

By adminstering proper dose of siddha medicine


practioners may salvage people from the clutches of
killer disease
NATUROPATHY & YOGA
TKDL
TKDL targets Indian Systems of Medicine, viz.,
Ayurveda, Unani, Siddha and Yoga available in public
domain. This is being documented by sifting and
collating the information on traditional knowledge
from the existing literature existing in local languages
such as Sanskrit, Urdu, Arabic, Persian and Tamil in
digitized format, which will be available in five
international languages which are English, German,
Spanish, French and Japanese.
Each Sloka is read and converted into a structured
language using Traditional Knowledge Resource
Classification by subject (Ayurveda, Unani, Siddha
or Yoga) experts. The codes are then filled into the
data entry screen. The Slokas are also saved in the
database. The translated version of all the TKRC
codes is ported in the database. The abstraction is
done by the subject experts. The codes once saved in
meta data directory are converted in different
languages based on Unicode technology. The
formulations are presently
TKDL acts as a bridge between formulations existing
in local languages and a Patent Examiner at a global
level, since the database will provide information on
modern as well as local names in a language and
format understandable to Patent Examiners. It is
expected that the issue of the gap on lack of access to
prior art traditional knowledge shall get addressed
 Set up by Ministry of Commerce on 12 May, 2004
Objective : To give Focused Attention to Pharma Exports
Supported by : All Major Pharma Associations
IDMA,BDMA,OPPI,IPA
Rs. 3 Crores Contribution by Government of Andhra
Pradesh. H.O. at Hyderabad , R.O. at Mumbai & New Delhi

-Autonomous in Nature
-Government nominees on the Board
-Provides commercially useful information & Assistance
-Professional advise in technology related matters
 Role of Pharmexcil:
-Organize visits of Delegations to Explore
Overseas Markets
-Participation in Trade Fairs / Exhibition
-Take up problems of members with the
Government Agencies
-Build a statistical base & provide data on Exports
Pharmexcil - Categories Covered
 Bulk drugs / drug intermediates
 Drug formulations
 Herbals / Ayurvedics / Homeopathic /
Unani
 Medicinal Plants
 Bio-tech / Biological products
 Diagnostics and Surgicals
 Neutraceuticals
 Collaborative /contract research
 Clinical trials
 Pharma consultancy services etc.`
ACTIVITIES OF PHARMEXCIL
Delegations/BSM to Abroad :
1.      Argentina, Chile, Peru Aug’08
2.      Uzbekistan, Turkmenistan, Kyrgyztan Feb 09
3.      Herbal Delegation to Brussels & EU countries Oct 09
Exhibitions Abroad:
CPhI Japan 9th-11th April 2008, Supply Side East, USA
28th-30th April 2008, MediPharma Expo, Vietnam 21st-
24th May 2008, CPhI, South America, Brazil 19th – 21st
Aug 2008, Apteka, Russia October 2008, CPhi Worldwide,
Germany 30th – 2nd Oct 2008
CphI India, Mumbai 28th – 30th November - Postponed
Informex 2009 USA, Jan 2009, Arab Health 2009 Dubai, Jan
2009, Asia Pharma Expo, Jan 2009
Seminars & Work Shops Completed
Hyderabad - April 2008, Mumbai- June 2008, Delhi – July 2008,
Bhubaneswar – Nov 2008
Kolkata, Ahmedabad, Lucknow, Baroda, Dehradun – Proposed
2009
Deptt of Ayush proposed Pharmexcil to have 3 international
events in 2009-10
FOR AYUSH……

NMPB: Various schemes for Cultivation of MAPs, preparation of Project


Reports, Documentary Film preparation, Establishment & maintenance of
Herbal Gardens & Nursery etc.

(evaluated cost of about Rs. 630 lacs for 11th 5 Yr plan.

Nurseries 4 – 20 Lacs

Cultivation 20% - 75% (depending on the species of cultivation selected)


Post Harvestment Management 5 Lacs (50%-100%)

Processing & Value addition 10- 50 lacs @ 25- 50%

Further details available on the NMPB web site


APEDA : 50% of analytical charges are reimbursed for testing
Egg powder, Honey & Grapes.

Vishesh Krishi Upaj Yojana: Duty Credit at 5% of the FOB


Value

Backward Regions Grant Fund: Grant of Rs 10 crore per


District (total 250 Districts) for providing technical assistance,
office infra structure, training, conduct of surveys, etc at
Panchayat level.

For new ideas:www.tdb.gov.in


conclusion

DRUG DISCOBERY IN INDIA IS DIFFICULT DUE TO THE LIMITED


RESAOURSCES AND, R & D OF PHARMACEUTICAL IS VERY
EXPENSIVE , DUE TO LONGER DRUG DISCOVERY PIPELINE AND
SUCCESS RATE IS AMPLE

INDIA HAS GREAT ANCIENT WEALTH OF AYURVEDA AND SIDDHA


THAT CLAIMS TO CURE KILLER DISEASE BUT ONLY LACUNAE IS
AVAILABILTY OF SCIENTIFIC EVIDENCE FOR INTERNATIONAL
MARKET.

IF WE COMBINE OUR TRADITONAL KNOWLEDGE AND SCIENTIFC


RESOURCES THEN IT WILL BE GREAT BOON FOR INDIA.

You might also like